Shikang Li

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Squamous Cell Carcinoma

Top Venues

Journal of cellular and molecular medicine

Briefings in bioinformatics

World journal of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhanyu Xu, Dongming He, Liuliu Huang, Kun Deng, Wei Jiang, Junqi Qin, Zhiwen Zheng, Tiaozhan Zheng, Shikang Li
Metabolic reprogramming-driven homologous recombination and TCA cycle dysregulation contribute to poor prognoses in lung adenocarcinoma. Journal of cellular and molecular medicine 28 (11) (2024)
Zhanyu Xu, Dongming He, Liuliu Huang, Kun Deng, Wei Jiang, Junqi Qin, Zhiwen Zheng, Tiaozhan Zheng, Shikang Li
Metabolic reprogramming-driven homologous recombination and TCA cycle dysregulation contribute to poor prognoses in lung adenocarcinoma. Journal of cellular and molecular medicine 28 (11) (2024)
Zhanyu Xu, Dongming He, Liuliu Huang, Kun Deng, Wei Jiang, Junqi Qin, Zhiwen Zheng, Tiaozhan Zheng, Shikang Li
Metabolic reprogramming-driven homologous recombination and TCA cycle dysregulation contribute to poor prognoses in lung adenocarcinoma. Journal of cellular and molecular medicine 28 (11) (2024)
Zhanyu Xu, Haibo Liao, Liuliu Huang, Qingfeng Chen, Wei Lan, Shikang Li
IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretability. Briefings in bioinformatics 25 (3) (2024)
Zhanyu Xu, Haibo Liao, Liuliu Huang, Qingfeng Chen, Wei Lan, Shikang Li
IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretability. Briefings in bioinformatics 25 (3) (2024)
Zhanyu Xu, Haibo Liao, Liuliu Huang, Qingfeng Chen, Wei Lan, Shikang Li
IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretability. Briefings in bioinformatics 25 (3) (2024)
Kun Deng, Shenghua Lin, Zhanyu Xu, Junqi Qin, Liqiang Yuan, Yu Sun, Jiangbo Wei, Tiaozhan Zheng, Zhiwen Zheng, Fanglu Qin, Shikang Li
A novel gene signature derived from the CXC subfamily of chemokine receptors predicts the prognosis and immune infiltration of patients with lung adenocarcinoma. Medicine 101 (41) (2022)
Junqi Qin, Zhanyu Xu, Kun Deng, Fanglu Qin, Jiangbo Wei, Liqiang Yuan, Yu Sun, Tiaozhan Zheng, Shikang Li
Development of a gene signature associated with iron metabolism in lung adenocarcinoma. Bioengineered 12 (1) (2021)
Fanglu Qin, Shenghua Lin, Kun Deng, Junqi Qin, Zhanyu Xu, Liqiang Yuan, Jiangbo Wei, Yu Sun, Tiaozhan Zheng, Shikang Li
Comprehensive analysis of angiogenesis subtype of squamous cell carcinoma. World journal of surgical oncology 19 (1) (2021)
Zhan-Yu Xu, Jiangbo Wei, Fang-Lu Qin, Yu Sun, Weiwei Xiang, Liqiang Yuan, Junqi Qin, Kun Deng, Tiaozhan Zheng, Shikang Li
Hypoxia-associated alternative splicing signature in lung adenocarcinoma. Epigenomics 13 (1) (2020)